Skip to main content

Table 1

From: P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine

Patient's (53: 35 F, 18 M) subjective judgement (point of view) about Diclofenac HPβCD 25 mg s.c. vs Diclofenac potassium 50 mg os

Ease of use

Speed of onset of action

Efficacy

Tolerability

 

Easier

Tot 48/53

F 32/35

M 16/18

Faster

Tot 50/53

F 33/35

M 17/18

Better

Tot 48/53

F 33/35

M 15/18

Better

Tot 51/53

F 35/351

M 16/18

Most frequent provided reasons

No need vessel and water

Time to attack resolution lower

1 Better working ability

2 Lower # second drug dose

3 light and noise sensitivity reduced

No adverse reaction